British Journal of Clinical Pharmacology

Correction

Pages: 1863-1863

Article date: August 2019

Correction

Pages: 1864-1864

Article date: August 2019

Correction

Pages: 1865-1865

Article date: August 2019

Issue Information

Pages: 1657-1658

Article date: August 2019

Hepatic exposure of metformin in patients with non‐alcoholic fatty liver disease

Pages: 1761-1770

Article date: August 2019

Authors: Elias Immanuel Ordell Sundelin, Lars Christian Gormsen, Sara Heebøll, Mikkel Holm Vendelbo, Steen Jakobsen, Ole Lajord Munk, Søren Feddersen, Kim Brøsen, Stephen Jacques Hamilton‐Dutoit, Steen Bønløkke Pedersen, Henning Grønbæk, Niels Jessen

Cannabinoid use in practice in Australasia—Better guidance and new drug information systems will be essential for prescribers

Pages: 1664-1665

Article date: August 2019

Authors: Jennifer H. Martin, Nicholas J. Talley

Ticagrelor and central sleep apnoea: Impact of withdrawal and reintroduction

Pages: 1855-1858

Article date: August 2019

Authors: Vincent Puel, Hélène Théophile, Isabelle Godard, Nathalie Raymond, Ghada Miremont‐Salamé, Philippe Gosse, Jean‐Louis Pépin, Antoine Pariente

Issue highlights

Pages: 1659-1660

Article date: August 2019

Comparison of pharmacokinetics and the exposure–response relationship of dapagliflozin between adolescent/young adult and adult patients with type 1 diabetes mellitus

Pages: 1820-1828

Article date: August 2019

Authors: David Busse, Weifeng Tang, Markus Scheerer, Thomas Danne, Torben Biester, Viktor Sokolov, David Boulton, Joanna Parkinson

Reply to ‘Hyperthermic intraperitoneal chemotherapy with oxaliplatin—Still not standard of care for patients with colorectal peritoneal metastases’ by Julianov and Saroglu

Pages: 1848-1849

Article date: August 2019

Authors: Loek A.W. Jong, Nielka P. Erp